Changes in Hospital Adverse Events and Patient Outcomes Associated With Private Equity Acquisition | Health Care Economics, Insurance, Payment | JAMA | JAMA Network

The point estimates were adjusted for age, sex, race and ethnicity, Medicare and Medicaid dual eligibility, and van Walraven-Elixhauser comorbidity score, with fixed effects for the year of discharge, major diagnostic category of the hospitalization (excluded for specific clinical categories), and hospital. The differential change was calculated as the mean of the difference-in-differences estimates across the 3 years after private equity acquisition. The year of acquisition was a washout period. Clinical conditions were classified using diagnosis related groups from the hospital admission. COPD indicates chronic obstructive pulmonary disease. The box contains values within the IQR (25th to 75th percentile). The bold horizontal line signifies the median (or 50th percentile). The upper whisker extends to the largest value less than the 75th percentile plus 1.5 times the IQR. The lower whisker extends to the smallest value greater than the 25th percentile minus 1.5 times the IQR. The ful

The point estimates were adjusted for age, sex, race and ethnicity, Medicare and Medicaid dual eligibility, and van Walraven-Elixhauser comorbidity score, with fixed effects for the year of discharge, major diagnostic category of the hospitalization (excluded for specific clinical categories), and hospital. The differential change was calculated as the mean of the difference-in-differences estimates across the 3 years after private equity acquisition. The year of acquisition was a washout period. Clinical conditions were classified using diagnosis related groups from the hospital admission. CO